Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+510K
-
Total reported value, excl. options
-
$474M
-
Value change
-
+$9.59M
-
Number of buys
-
48
-
Number of sells
-
-69
-
Price
-
$19.29
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2019
138 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2019.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 50.5M outstanding shares and own 48.62% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.13M shares), VANGUARD GROUP INC (2.36M shares), DIMENSIONAL FUND ADVISORS LP (1.81M shares), FEDERATED HERMES, INC. (1.75M shares), STATE STREET CORP (1.11M shares), Invesco Ltd. (1.1M shares), RENAISSANCE TECHNOLOGIES LLC (833K shares), Voya Investment Management LLC (560K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (521K shares), and GEODE CAPITAL MANAGEMENT, LLC (505K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.